University of Galway (NUIG)
NUIG –www.universityofgalway.ie – AutoCRAT Coordinator
Established in 1845, the University of Galway is a research-led university ranked among the top 2% of universities in the world (QS World rankings 2019 and the Times Higher Education World University Rankings for 2019-20).
The Regenerative Medicine Institute (REMEDI) is a world-class, state-of-the-art research biomedical research centre at the University of Galway, whose main focus is research into regenerative medicine. REMEDI is a collaborative effort involving scientists, clinicians and engineers who share a vision for the development of novel therapies and tissue engineering solutions for human diseases using adult stem cells and gene therapies, with osteoarthritis as a major disease focus.
The University of Galway will be involved in all aspects of AutoCRAT. The U of Galway team will work on the discovery and validation of novel regenerative cell therapeutics. U of Galway will lead workstreams on (i) the development of GMP-compliant, scalable, automatable AutoCRAT production processes and (ii) regulatory compliance and economic evaluation of the AutoCRAT production platform. The U of Galway will also lead on ethics and project management.
The Team
Prof. Mary Murphy (AutoCRAT Coordinator) and Prof. Frank Barry lead the NUIG team.

Prof. Mary Murphy

Prof. Frank Barry